Bubs Australia Ltd. · ASX:BUB
Bubs Australia — Investor Presentation (September 2020)
16 slides from Bubs Australia's investor presentation, Sep 3, 2020
Slide 1: Capital Raising Presentation
ASX: BUB Bubs Australia CAPITAL RAISING PRESENTATION 3 September 2020 NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES
Slide 2: Disclaimer
CAPITAL RAISING PRESENTATION Disclaimer DISCLAIMER This investor presentation (Presentation) is dated 3 September 2020 and has been prepared by Bubs Australia Limited (ACN 060 094 742) (Bubs or the Company). By attending an investor presentation or briefing, or accepting, accessing or reviewing this
Slide 3: Disclaimer
CAPITAL RAISING PRESENTATION Disclaimer DISCLAIMER Investment risk An investment in Bubs shares is subject to known and unknown risks, some of which are beyond the control of Bubs and its directors. Bubs does not guarantee any particular rate of return or the performance of Bubs nor does it guarante
Slide 4: Disclaimer
CAPITAL RAISING PRESENTATION Disclaimer DISCLAIMER To the maximum extent permitted by law, Bubs and the Joint Lead Manager and their respective related bodies corporate and affiliates, and their respective officers, directors, employees, agents and advisers: (i) disclaim all responsibility and liabi
Slide 5: Capital Raising
CAPITAL RAISING PRESENTATION CAPITAL RAISING
Slide 6: Executive Summary
CAPITAL RAISING PRESENTATION Capital Raising EXECUTIVE SUMMARY FY20 TRADING UPDATE FY20 Gross Revenue1 increased 32% to $62 million. Strong revenue growth momentum achieved over pcp. Infant Formula FY20 Gross Revenue1 growth 69% pcp. Contribution share of Infant Formula increases from 30% to 55% ove
Slide 7: Capital Raise Overview
CAPITAL RAISING PRESENTATION Capital Raising CAPITAL RAISE OVERVIEW OFFER SIZE AND Institutional placement raising up to $28.3 million and SPP to raise up to $10 million STRUCTURE (with Bubs retaining discretion to increase amount raised under the SPP and to scale back applications on a pro rata bas
Slide 8: Equity Raising Overview
CAPITAL RAISING PRESENTATION Capital Raising EQUITY RAISING OVERVIEW Approximately $38.3 million equity raise, with $28.3 million institutional placement and $10 million Share Purchase Plan* FINANCIAL IMPACT PRO FORMA BALANCE SHEET Post-equity raise pro forma ($million) Pre-equity Post-equity raise2
Slide 9: Use of Funds
CAPITAL RAISING PRESENTATION Capital Raising USE OF FUNDS1 1. Balance sheet flexibility and growth capital. FY21 growth initiatives include: % allocation ($million) - Support ‘Vita Bubs’ launch into high margin adjacent VMS category - Accelerate brand equity build in Global Brand Ambassador a
Slide 10: Indicative Timetable
CAPITAL RAISING PRESENTATION Capital Raising INDICATIVE TIMETABLE Description Date Trading Halt Monday, 31 August 2020 Announcement of Bubs Results for the year ended 30 June 2020 Bookbuild conducted for the Placement Tuesday, 1 September 2020 Record Date for SPP Wednesday, 2 September 2020, 7:00pm
Slide 11: Key Risks
CAPITAL RAISING PRESENTATION Capital Raising KEY RISKS There are a number of risks that are both specific to Bubs and its subsidiaries (Group) and of a general nature, which may affect the future operating and financial performance of the Group and the outcome of any investment in the Group. This se
Slide 12: Key Risks
CAPITAL RAISING PRESENTATION Capital Raising KEY RISKS Reliance on third parties generally As part of its ongoing commercial activities the Group enters into contracts with various third parties, including suppliers, processors, distributors and customers. The ability of these third parties to meet
Slide 13: Key Risks
CAPITAL RAISING PRESENTATION Capital Raising KEY RISKS 2. COMPLIANCE AND REGULATORY RISKS Foreign regulatory risk and regulatory risk Laws and regulations affect the Group’s operations. There is a risk that a failure to comply with such laws or an adverse decision or change in policy by a regulatory
Slide 14: Key Risks
CAPITAL RAISING PRESENTATION Capital Raising KEY RISKS markets; investor sentiment; Australian and international economic conditions and outlooks; changes in investor sentiment towards specific sectors of the market; changes in interest rates and the rate of inflation; changes in government legislat
Slide 15: Company and Joint Lead Managers
CAPITAL RAISING PRESENTATION Capital Raising Company Joint Lead Manager Joint Lead Manager Bubs Australia Limited Bell Potter PAC Partners (ASX: BUB) Securities Limited Securities Limited 23-29 Nina Link Level 29, Level 10, Dandenong South 101 Collins Street 330 Collins Street VIC 3175 Melbou
Slide 16: Bubs Australia: Growing Generation Joy
ASX: BUB Bubs Australia Growing Generation Joy™
Bubs Australia — Investor Presentation (September 2020) on 6ix